Fluvoxamine, melatonin and COVID-19

Psychopharmacology (Berl). 2021 Feb;238(2):611. doi: 10.1007/s00213-020-05753-z. Epub 2021 Jan 4.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • COVID-19*
  • Clinical Deterioration*
  • Fluvoxamine
  • Humans
  • Melatonin*
  • Outpatients
  • SARS-CoV-2

Substances

  • Melatonin
  • Fluvoxamine